Aurora Improves Offerings in Australia With New Range of Premium Dried Flower Products
Aurora Improves Offerings in Australia With New Range of Premium Dried Flower Products
NASDAQ | TSX: ACB
纳斯达克 | 多伦多证券交易所：ACB
Canada's Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for Patients
加拿大领先的医用大麻公司和澳大利亚MedreLeaf推出创新产品，为患者提供更多选择
EDMONTON, AB, April 30, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – the Canadian based leading global medical cannabis company, in conjunction with MedReleaf Australia, is pleased to announce the expansion of its portfolio with the introduction of a new range of premium dried cannabis flower products. Now available for doctors to prescribe to patients in Australia, the new products developed by Aurora and manufactured at its EU-GMP and TGA-GMP certified facility, will be distributed by MedReleaf Australia, a premier distributor of medical cannabis products holding the second position in the Australian market.
艾伯塔省埃德蒙顿，2024 年 4 月 30 日 /PRNewswire/- 奥罗拉大麻公司 纳斯达克股票代码：ACB）（多伦多证券交易所股票代码：ACB）——这家总部位于加拿大的全球领先医用大麻公司与澳大利亚MedreLeaf合作，很高兴地宣布扩大其产品组合，推出了一系列新的优质干大麻花产品。由Aurora开发并在其欧盟GMP和TGA-GMP认证的工厂生产的新产品现在可供澳大利亚医生为患者开处方，将由澳大利亚市场上排名第二的医用大麻产品的主要分销商MedreLeaf Australia分销。